# Propanc Biopharma, Inc. (PPCB)

> Healthcare · AU · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PPCB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -6.36M | $ -1.14M | $ 108.6K | $ 9.83M |
| 2025 | $ 0 | $ -67.65M | $ -3.21M | $ 1.68M | $ 10.45M |
| 2024 | $ 0 | $ -1.76M | $ -609.2K | $ 1.21M | $ -4.16M |
| 2023 | $ 0 | $ -2.70M | $ -1.03M | $ 1.02M | $ -3.56M |
| 2022 | $ 0 | $ -2.76M | $ -1.59M | $ 741.5K | $ -2.92M |
| 2021 | $ 0 | $ -2.96M | $ -1.72M | $ 920.1K | $ -2.93M |
| 2020 | $ 0 | $ -2.82M | $ -856.0K | $ 1.16M | $ -3.61M |
| 2019 | $ 0 | $ -7.15M | $ -2.73M | $ 2.79M | $ -5.67M |
| 2018 | $ 0 | $ -8.57M | $ -2.30M | $ 2.71M | $ -3.90M |
| 2017 | $ 0 | $ -9.61M | $ -2.95M | $ 4.29M | $ -7.15M |
| 2016 | $ 0 | $ -10.62M | $ -5.20M | $ 1.81M | $ -3.84M |
| 2015 | $ 0 | $ -9.4K | N/A | N/A | N/A |
| 2014 | $ 0 | $ -1.9K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.36 |
| Current Ratio | 2.37 |

## Other views

- [Metrics](https://sponda.capital/en/PPCB.md)
- [Charts](https://sponda.capital/en/PPCB/charts.md)
- [Compare](https://sponda.capital/en/PPCB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.